SCHEMBL6074340

SCHEMBL6074340

COc1ccc2c(c1)CC(C)(C)C(=O)N2C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.49
MAPT P10636 4/20 0.44
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TSHR P16473 1/20 0.44
ALOX15 P16050 2/20 0.43
NQO2 P16083 1/20 0.43
NOTUM Q6P988 1/20 0.42
SNCA P37840 2/20 0.42
POLB P06746 2/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41
CASP1 P29466 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TRIM24 O15164 1/20 0.41
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
SRD5A1 P18405 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6606022 0.76 LMNA (0.57) LMNAMAPTALDH1A1KDM4ESMN1; SMN2
SCHEMBL3519128 0.76 MAPT (0.49) LMNAMAPTALDH1A1KDM4ESMN1; SMN2
SCHEMBL578369 0.76 LMNA (0.60) LMNAALDH1A1NOTUMPOLBMEN1
SCHEMBL2470209 0.75 NOTUM (0.46) LMNAMAPTALDH1A1KDM4ETSHR
SCHEMBL38662728 0.74 DRD1 (0.58) LMNANOTUMSNCAHSD17B10DRD2
SCHEMBL28250120 0.74 MAPT (0.60) LMNAMAPTALDH1A1KDM4ETSHR
SCHEMBL6073478 0.74 TRIM24 (0.64) LMNANOTUMPOLBHSD17B10TRIM24
SCHEMBL6073600 0.74 LMNA (0.51) LMNAMAPTALDH1A1TSHRNQO2
SCHEMBL11091178 0.73 DRD1 (0.45) LMNAMAPTALDH1A1KDM4ENOTUM
SCHEMBL9366946 0.73 MAPT (0.44) LMNAMAPTALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7119207-B2 Benzoamide piperidine containing compounds and related compounds PFIZER INC (US) 2006-10-10 US disclosed
US-20030087925-A1 Benzoamide piperidine containing compounds and related compounds PFIZER INC. 2003-05-08 US disclosed
EP-1272484-A2 BENZOAMIDE PIPERIDINE COMPOUNDS AS SUBSTANCE P ANTAGONISTS Pfizer Products Inc. (US) 2003-01-08 EP disclosed
WO-2001077100-A2 BENZOAMIDE PIPERIDINE COMPOUNDS AS SUBSTANCE P ANTAGONISTS PFIZER PRODUCTS INC. (US) 2001-10-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030087925-A1 Benzoamide piperidine containing compounds and related compounds TACR1, VIPR1, VIPR2 LMNA 3704/4885MAPT 2751/4885ALDH1A1 732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.